Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (421-430 of 681) with videos related to

Pageof 69
Sort By:
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
AIDS (London, England)|February 19, 2005
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimenChristian Holkmann Olsen, Jose Gatell, Bruno Ledergerber, et al.
Cells|December 23, 2022
Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut MicrobiomeRamtin Zargari Marandi, Mette Jørgensen, Emma Elizabeth Ilett, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2019
Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patientsJens-Ulrik Stæhr Jensen, Lars Peters, Theis S Itenov, et al.
AIDS (London, England)|May 26, 2011
Tuberculosis among HIV-positive patients across Europe: changes over time and risk factorsAlexey Kruk, Wendy Bannister, Daria N Podlekareva, et al.
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
HIV Medicine|November 17, 2004
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA studyA Mocroft, A d'Arminio Monforte, O Kirk, et al.
Pageof 69

Showing results (421-430 of 681) with videos related to

Sort By:
Pageof 69
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
AIDS (London, England)|February 19, 2005
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimenChristian Holkmann Olsen, Jose Gatell, Bruno Ledergerber, et al.
Cells|December 23, 2022
Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut MicrobiomeRamtin Zargari Marandi, Mette Jørgensen, Emma Elizabeth Ilett, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2019
Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patientsJens-Ulrik Stæhr Jensen, Lars Peters, Theis S Itenov, et al.
AIDS (London, England)|May 26, 2011
Tuberculosis among HIV-positive patients across Europe: changes over time and risk factorsAlexey Kruk, Wendy Bannister, Daria N Podlekareva, et al.
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
HIV Medicine|November 17, 2004
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA studyA Mocroft, A d'Arminio Monforte, O Kirk, et al.
Pageof 69